Following an excellent presentation at the EAACI Digital Congress 2020, we caught up with Prof. Lavinia Davidescu (University of Oradea, Romania). We discussed the findings from the phase 3 study of masitinib in the treatment of patients with severe persistent asthma (NCT01449162) and what the future holds.
1. Could you tell us a little about masitinib and its mechanism of action? (0:04)
2. Could you give us an overview of Study AB07015 and its major efficacy and safety findings? (1:24)
3. What were the findings of the subgroup analysis in eosoniphilic asthma patients, and what are the implications of these findings? (04:29)
4. What future studies are planned? (11:26)
Speaker disclosure: Lavinia Davidescu is the coordinating investigator of masitinib study AB07015 in severe asthma uncontrolled with oral corticosteroids.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the EAACI Digital Congress 2020.
Related Videos In Asthma
Richard van Zyl-Smit, ERS 2020 – Optimising Inhaled Therapies for Asthma
Richard van Zyl-Smit (University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa) kindly took the time to speak with us about maximising the benefit of inhaler therapy and recent development being made in this field. Questions What are the major unmet needs in the use of inhaled therapies for the control of […]
Peter J Barnes, ERS 2020 – Smart Inhalers for COPD and Asthma
During the ERS International Congress 2020, it was great to catch up with our Editorial Board member, Prof. Peter J Barnes (Imperial College, London, UK), to continue the discussion around Smart Inhalers and how they could help optimise inhaler use in patients. Questions How common is poor adherence and inhaler technique in people with asthma […]
Liam Heaney, ERS 2020 – Corticosteroid Optimisation using Composite Biomarkers
Following his recent publication in the Lancet Respiratory Medicine, and presentation at the ERS Congress, we spoke with Prof. Liam Heaney (Queen’s University, Belfast, Northern Ireland, UK) about the composite biomarker approach to optimising steroid dosage in patients with severe asthma. Questions Why is there a need for new approaches to optimising steroid dosage in people […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!